“Immune Checkpoint Blockade in Cancer Therapy: Historical Perspective, New Insights, and Prospects for Cures”
Hosted by the Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs), the symposium features distinguished scientists and profile remarkable advances in the development of treatment options for cancer, infectious diseases, autoimmune disorders, and brain tumors.
8:30 to 8:35 Welcome by Robert Schreiber, Ph.D.
8:35 to 8:45 Comments by Mr. Andrew M. Bursky
8:45 to 8:55 Comments by Dean David H. Perlmutter, M.D., with introduction of new Chancellor
8:55 to 9:05 Comments by Chancellor Elect Andrew D. Martin
9:05 to 10:05 James P. Allison, Ph.D., Keynote Speaker:“Immune Checkpoint Blockade in Cancer Therapy: Historical Perspective, New Insights, and Prospects for Cures”
10:05 to 10:50 Marco Colonna, M.D. (WashU Pathology & Immunology): “ILC Recognition of Tumor Cells”
10:50 to 11:35 Shabaana Khader, Ph.D. (WashU Molecular Microbiology): “Human Tuberculosis: A moving target”
11:35 to 12:20 John P. Atkinson, M.D. (WashU Medicine, Rheumatology): “Genetic Variants in Complement Regulators Causing Human Disease”
12:45 to 1:45 Lunch for invited guests in the Great Room (EPNEC)
** Keynote speaker will speak for 50 minutes followed by 10 minutes of Q&A;
Invited speakers will speak for 40 mins. each followed by 5 minutes for Q&A.
For inquiries contact Amy Johnson.